Another study in hepatocellular carcinoma (HCC) cells found that METTL3 promoted proliferation by inhibiting the expression of SOCS2, a transcription factor that can negatively regulate cell proliferation, through m6A-dependent/YTHDF2-mediated mRNA degradation (Chen M. et al., 2018). Here, SOCS2 is linked to hepatocellular carcinoma.